G. Forrest et al., DETERMINATION OF GABAPENTIN IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 681(2), 1996, pp. 421-425
Citations number
16
Categorie Soggetti
Chemistry Analytical","Biochemical Research Methods
Journal title
Journal of chromatography B. Biomedical applications
A rapid and simple method for determination of the novel antiepileptic
compound gabapentin [1-(aminomethyl)cyclohexaneacetic acid] in plasma
is described. Blank human plasma was spiked with gabapentin (1.0-10.0
mu g/ml) and internal standard [1-(aminomethyl)-cycloheptaneacetic ac
id; 5.0 mu g/ml]. Individual samples were treated with 2 M perchloric
acid, centrifuged and then derivatised with o-phthalaldehyde-3-mercapt
opropionic acid. Separation was achieved on a Beekman Ultrasphere 5 mu
m reversed-phase column with mobile phase consisting of 0.33 M acetat
e buffer (pH 3.7; containing 100 mg/l EDTA)-methanol-acetonitrile (40:
30:30, v/v). Eluents were monitored by fluorescence spectroscopy with
excitation and emission wavelengths of 330 and 440 nm, respectively. T
he calibration curve for gabapentin in plasma was linear (r=0.9997) ov
er the concentration range 1.0-10.0 mu g/ml. Recovery was seen to be g
reater than or equal to 90%. The inter- and intra-assay variations for
three different gabapentin concentrations were less than or equal to
10% throughout. The lower limit of quantitation was found to be 0.5 mu
g/ml. Chromatography was unaffected by a range of commonly employed a
ntiepileptic drugs or selected amino acids.